NO982265L - Diagnostikk for og mediatorer for inflammatoriske forstyrrelser - Google Patents

Diagnostikk for og mediatorer for inflammatoriske forstyrrelser

Info

Publication number
NO982265L
NO982265L NO982265A NO982265A NO982265L NO 982265 L NO982265 L NO 982265L NO 982265 A NO982265 A NO 982265A NO 982265 A NO982265 A NO 982265A NO 982265 L NO982265 L NO 982265L
Authority
NO
Norway
Prior art keywords
host
mediators
diagnosis
kit
inflammatory disorders
Prior art date
Application number
NO982265A
Other languages
English (en)
Other versions
NO982265D0 (no
Inventor
Sampath Parthasarathy
Russel M Medford
Wayne R Alexander
Original Assignee
Atherogenics Inc
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atherogenics Inc, Univ Emory filed Critical Atherogenics Inc
Publication of NO982265D0 publication Critical patent/NO982265D0/no
Publication of NO982265L publication Critical patent/NO982265L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

En fremgangsmåte for et sett for diagnostisering og kvantifisering av oksidasjonstilstanden, og spesifikt, nivå av lipid peroksidasjon, til en vert er tilveiebrakt og innbefatter kontakting av vertens biologiske prøve med et antistoff mot et antigen dannet ved omsetning av et lipidhydroperoksid med et primært amin. Denne fremgangsmåten vurderer risiko for, eller eksistensen av, oksidativ skade i verten. Det er også beskrevet monoklonale og polyklonale antistoffer, samt antistoff-fragmenter, eventuelt i renset eller isolert form, som er nyttige i denne fremgangsmåten og dette settet.
NO982265A 1996-09-20 1998-05-18 Diagnostikk for og mediatorer for inflammatoriske forstyrrelser NO982265L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2640196P 1996-09-20 1996-09-20
US3933397P 1997-03-17 1997-03-17
PCT/US1997/016695 WO1998012561A1 (en) 1996-09-20 1997-09-19 Diagnostics for and mediators of inflammatory disorders

Publications (2)

Publication Number Publication Date
NO982265D0 NO982265D0 (no) 1998-05-18
NO982265L true NO982265L (no) 1998-07-16

Family

ID=26701197

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982265A NO982265L (no) 1996-09-20 1998-05-18 Diagnostikk for og mediatorer for inflammatoriske forstyrrelser

Country Status (16)

Country Link
US (1) US20020052000A1 (no)
EP (1) EP0883811A1 (no)
JP (1) JP2000500879A (no)
KR (1) KR19990071477A (no)
AU (1) AU722625B2 (no)
BG (1) BG102541A (no)
BR (1) BR9710402A (no)
CA (1) CA2237191A1 (no)
CZ (1) CZ146598A3 (no)
EA (1) EA002520B1 (no)
HU (1) HUP0102907A1 (no)
NO (1) NO982265L (no)
NZ (1) NZ330475A (no)
PL (1) PL326750A1 (no)
SK (1) SK66198A3 (no)
WO (1) WO1998012561A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225070B1 (en) 1997-08-07 2001-05-01 The Regents Of The University Of California Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
WO2000028072A1 (en) * 1998-11-06 2000-05-18 Emory University Biomarkers for oxidative stress
US6953666B1 (en) 1998-11-06 2005-10-11 Emory University Biomarkers for oxidative stress
JP4629175B2 (ja) * 1999-12-16 2011-02-09 日油株式会社 モノクローナル抗体
US6495335B2 (en) 2000-12-07 2002-12-17 Mario Chojkier Compositions and methods for diagnosing alzheimer's disease
US20040121350A1 (en) * 2002-12-24 2004-06-24 Biosite Incorporated System and method for identifying a panel of indicators
US20040126767A1 (en) * 2002-12-27 2004-07-01 Biosite Incorporated Method and system for disease detection using marker combinations
US20030199000A1 (en) * 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
US20040253637A1 (en) * 2001-04-13 2004-12-16 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
US20040203083A1 (en) * 2001-04-13 2004-10-14 Biosite, Inc. Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
WO2003016910A1 (en) * 2001-08-20 2003-02-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040209307A1 (en) * 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
EP1613946A4 (en) * 2003-03-20 2006-07-12 Univ Northeastern Ohio INCLUDED TEST DEVICE FOR FAST DETECTION OF BIOLOGICAL CONTAMINANTS
US20060009522A1 (en) * 2004-07-01 2006-01-12 Reza Dana Compositions and methods for treating eye disorders and conditions
US20070265341A1 (en) * 2004-07-01 2007-11-15 The Schepens Eye Research Institute Inc. Compositions and methods for treating eye disorders and conditions
US8129123B2 (en) 2004-10-05 2012-03-06 The Regents Of The University Of California Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios
KR101230740B1 (ko) * 2010-09-08 2013-02-07 인제대학교 산학협력단 자간전증의 조기 진단 및 예후 평가 방법
EP3546446A1 (en) * 2013-11-15 2019-10-02 DS Biopharma Limited Pharmaceutically acceptable salts of polyunsaturated hydroxy fatty acids
PL3311158T3 (pl) 2015-06-19 2023-11-27 Sera Prognostics, Inc. Pary biomarkerów do przewidywania przedwczesnego porodu
EP3668996A4 (en) 2017-08-18 2021-04-21 Sera Prognostics, Inc. CLOCK PREGNANCY PROTEIN FOR PREDICTING THE DATE AND TIME TO BIRTH

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675281A (en) * 1984-07-09 1987-06-23 Lands William E M Quantification of hydroperoxides using prostaglandin H synthase
US5807884A (en) * 1992-10-30 1998-09-15 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5380747A (en) * 1992-10-30 1995-01-10 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
JPH08500740A (ja) * 1993-06-25 1996-01-30 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー リポタンパク質関連ホスホリパーゼａ▲下２▼、その阻害剤および診断および治療におけるその使用
US5939535A (en) * 1995-10-27 1999-08-17 The Board Of Regents Of The University Of Nebraska Acetaldehyde and malondialdehyde protein adducts

Also Published As

Publication number Publication date
WO1998012561A1 (en) 1998-03-26
US20020052000A1 (en) 2002-05-02
EA199800460A1 (ru) 1998-12-24
CA2237191A1 (en) 1998-03-26
PL326750A1 (en) 1998-10-26
EP0883811A1 (en) 1998-12-16
AU722625B2 (en) 2000-08-10
BR9710402A (pt) 1999-08-17
NZ330475A (en) 1999-11-29
BG102541A (en) 1999-02-26
NO982265D0 (no) 1998-05-18
JP2000500879A (ja) 2000-01-25
SK66198A3 (en) 1999-09-10
CZ146598A3 (cs) 1998-11-11
KR19990071477A (ko) 1999-09-27
HUP0102907A1 (hu) 2004-05-28
AU4647397A (en) 1998-04-14
EA002520B1 (ru) 2002-06-27

Similar Documents

Publication Publication Date Title
NO982265L (no) Diagnostikk for og mediatorer for inflammatoriske forstyrrelser
ES2094733T3 (es) Deteccion de enfermedades o disfunciones neurologicas.
NO20006681D0 (no) Fremgangsmåte ved tidlig diagnose av karsinomer
ATE114672T1 (de) Peptidzusammensetzung und verfahren zum nachweis von antikörpern gegen htlv-iii.
DE69937368D1 (de) Nachweis von erkrankungen der nieren und behandlung
AU7652194A (en) A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
ES2138102T3 (es) Procedimiento para la deteccion de antigeno urinario asociado a tumores.
NO964015L (no) Fremgangsmåte for påvisning av kalpain-aktivering og identifisering av kalpain-inhibitorer
ATE74662T1 (de) Immunoanalysetestverfahren fuer cholesterolepoxide.
NO163920C (no) Fremgangsmaate for bestemmelse av pivka-ii i fysiologiske proever.
EP0230934A3 (en) Monoclonal antibody, measuring method of glucosylated protein by utilizing the monoclonal antibody, and kit therefor.
DE68921151D1 (de) Substrat-Zusammensetzung für Alkali-Phosphatase sowie ihre Verwendung bei Testverfahren.
ATE44621T1 (de) Proteinkonjugate von penicillosaeure, ihre herstellung und verwendung.
DK0991945T3 (da) Fremgangsmåde til identifikation af tumor-antigener med antistoffer i serum
BR9100924A (pt) Linha de celulas de hibridoma,mutantes,anticorpos,processo para a preparacao de uma linha de celulas de hibridoma,processo para a preparacao de anticorpos,processo e agente para a prova imunologica de metolacloro,derivado de metolacloro e processo para sua preparacao
PL366996A1 (en) Method and means for detecting gluten-induced diseases
AU2001274239A1 (en) Neurotransmission disorders
KR870002453A (ko) 프로좀 단백질에 대한 단일항체의 제조방법 및 그를 이용한 프로좀과 관련된 현상의 검출 및 질병의 진단법
EP0364971A3 (en) Process for the detection of legionella antigens in body fluids and the like, as well as a test kit for performing the process
NO165128C (no) Fremgangsmaate for eliminering av falske positive resultater fra systemiske lupuserythematodes-pasienter ved bestemmelse av et atl-virusantistoff i en testproeve.
ATE110470T1 (de) Immuntestverfahren von chondrocalcin.
ES2160783T3 (es) Metodos para detectar parvovirus humano.
WO2000064469A3 (en) Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds
AU2562088A (en) Detection of tumor-associated markers in biological fluids
MX9704717A (es) Antigeno, anticuerpos y ensayo de diagnostico para la enfermedad de alzheimer.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application